Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
GHK-Cu (GHK) is a healing peptide, at the preclinical stage in the published literature. Copper tripeptide complex naturally found in plasma. Declines with age and plays roles in wound healing, collagen synthesis, and antioxidant activity.
Copper tripeptide complex naturally found in plasma. Declines with age and plays roles in wound healing, collagen synthesis, and antioxidant activity.
| Research Status | Preclinical |
|---|---|
| Half-Life | 4-6 hours |
| Administration | Subcutaneous or topical |
| Doses Reported in Published Studies | 1-3 mg |
Copper delivery for enzyme function, stimulates collagen and glycosaminoglycan synthesis, antioxidant gene activation.
Copper tripeptide complex naturally found in plasma. Declines with age and plays roles in wound healing, collagen synthesis, and antioxidant activity.
Copper delivery for enzyme function, stimulates collagen and glycosaminoglycan synthesis, antioxidant gene activation.
GHK-Cu is at the following stage in the published literature: Preclinical. All information is for research and educational purposes only.
Reported half-life: 4-6 hours.
Reported administration route in the literature: Subcutaneous or topical. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.